GAO: Rise in Drug Shortages Harming Patients

A pharmacist pours Truvada pills back into the bottle at Jack's Pharmacy on November 23, 2010 in San Anselmo, California.
National Journal
Clara Ritger
Add to Briefcase
See more stories about...
Clara Ritger
Feb. 10, 2014, 1:52 p.m.

The num­ber of drug short­ages has quad­rupled in the past five years, for­cing doc­tors and phar­macists to delay or ra­tion care, as life-sav­ing med­ic­a­tions re­main in short sup­ply, ac­cord­ing to the Gov­ern­ment Ac­count­ab­il­ity Of­fice on Monday.

There were 456 drug short­ages in 2012, and the trend was con­tinu­ing, with an­oth­er 361 drug short­ages re­por­ted by the middle of 2013, ac­cord­ing to the GAO re­port.

Drug-qual­ity is­sues and man­u­fac­tur­ing delays or shut­downs re­lated to qual­ity ac­coun­ted for 70 per­cent of drug short­ages re­por­ted between Jan. 1, 2011, and June 30, 2013, ac­cord­ing to the re­port.

The scarcity of cer­tain drugs in the mar­ket has jeop­ard­ized the abil­ity of care pro­viders to sta­bil­ize trauma vic­tims, con­trol pain dur­ing sur­gery, and treat heart dis­ease, said Mar­cia Crosse, GAO’s dir­ect­or of health care, at a con­gres­sion­al hear­ing on the re­port.

“The large num­ber of short­ages re­por­ted to the FDA sug­gests the mar­ket is still at risk of sup­ply dis­rup­tions,” Crosse said.

The Food and Drug Ad­min­is­tra­tion is re­spons­ible for over­see­ing drug qual­ity-prob­lems and work­ing with man­u­fac­tur­ers to rem­edy short­ages. Con­gress gran­ted the FDA great­er over­sight powers in 2012 after it passed the Food and Drug Ad­min­is­tra­tion Safety and In­nov­a­tion Act, re­quir­ing man­u­fac­tur­ers to no­ti­fy the agency of short­ages and re­quir­ing the agency to main­tain short­age data­bases and cre­ate ac­tion plans to solve them.

GAO cred­ited the FDA with mak­ing pro­gress in its goal to in­crease the avail­ab­il­ity of drugs, par­tic­u­larly gen­er­ics, in the face of short­ages. The FDA’s ef­forts to get drugs back on the mar­ket in­clude reg­u­lat­ory flex­ib­il­ity and ex­ped­ited re­views of new drugs.

While the num­ber of over­all drug short­ages re­mains high, the num­ber of new drug short­ages is fall­ing. There were 195 new short­ages in 2012, down from 255 in 2011.

“Our next task is to un­der­stand those longer-dur­a­tion short­ages,” said Douglas Throck­mor­ton, deputy dir­ect­or of reg­u­lat­ory pro­grams at the FDA.

Roughly 64 per­cent of new drug short­ages — 722 of the 1,132 re­por­ted to the FDA between Janu­ary 2007 and June 2013 — las­ted less than one year. But 14 per­cent las­ted more than two years, and some as long as four or more.

GAO re­com­mends that the FDA im­prove its data­base of drug short­ages and use the in­form­a­tion to ana­lyze trends and identi­fy risk factors to pre­vent fu­ture de­fi­cien­cies.

What We're Following See More »
UNANIMOUS DECISION
SCOTUS Rules Against Venue Shopping in Patent Cases
58 minutes ago
THE DETAILS

Writing for an 8-0 Supreme Court on Monday, Justice Clarence Thomas wrote that patent lawsuits "must be brought in the state where the defendant company is incorporated. ... The ruling likely spells an end to the near-monopoly the federal court in the Eastern District of Texas holds in handling patent cases. Plaintiffs for decades have filed suits in that pro-plaintiff district based on a broader interpretation of venue that made suits possible almost anywhere."

Source:
BASED ON FIFTH AMENDMENT
Flynn To Refuse To Cooperate With Subpoena
1 hours ago
BREAKING

Former National Security Adviser to President Donald Trump Michael Flynn will refuse to cooperate with a subpoena from the Senate Intelligence Committee. "Flynn will invoke his Fifth Amendment protection against self-incrimination." Flynn was unlikely to turn over any documents without being granted immunity, as he "has previously sought immunity from 'unfair prosecution.'"

Source:
UNCERTAINTY THROUGH AUGUST
White House To Request Second 90-Day Delay In Obamacare Subsidy Case
2 hours ago
BREAKING

The Trump administration plans to ask a federal court Monday for a second 90-day delay in a lawsuit over Obamacare subsidies. The lawsuit, House vs. Price, revolves around the Obamacare co-payment program, which pays health insurers who partake in the Obamacare exchanges to ensure that people without means can gain coverage without having to pay unaffordable co-payments.

ISOLATION VS. OPENNESS
Trump Puts Rouhani in a Tough Spot
2 hours ago
THE DETAILS

"On Sunday, U.S. President Donald Trump called on the world to isolate Iran," to the delight of his Sunni hosts, Saudi Arabia. Meanwhile, however, on Saturday, "Iranians poured into the streets by the hundreds of thousands to celebrate the re-election of President Hassan Rouhani, whose message of opening up to the West helped him to trounce a hard-line challenger."

Source:
TILLERSON SAYS IT’S PART OF JERUSALEM
Trump Becomes First President To Visit Western Wall
3 hours ago
BREAKING
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login